NCT05096338View on ClinicalTrials.gov

Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Prostate Cancer

Active, not recruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

October 27, 2021

Primary Completion Date

November 30, 2029

Study Completion Date

November 30, 2029

Conditions
Prostate CancerCardiotoxicityDrug-Related Side Effects and Adverse ReactionsCardiovascular Diseases
Interventions
OTHER

Social Determinants of Health

We will perform detailed phenotyping of Social Determinants of Health using the National Institute of Minority Health and Health Disparities PhenX SDOH toolkit at baseline.

Trial Locations (1)

19104

University of Pennsylvania, Philadelphia

All Listed Sponsors
collaborator

American Heart Association

OTHER

lead

Abramson Cancer Center at Penn Medicine

OTHER